TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
Sign in to add to a watchlist →
lobbying_client · US · canonical: tiber creek health strategies on behalf eli lilly · 2 aliases · 3 outbound · 8 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Jonathon Jones · lda_lobbyist_client
- 2026-05-18 · lobbied by John Michael Gonzalez · lda_lobbyist_client
- 2026-05-18 · lobbied by James Bryant Hall Ii · lda_lobbyist_client
- 2026-05-18 · lobbied by Emily Kirlin · lda_lobbyist_client
- 2026-05-18 · lobbied by Timothy A Molino · lda_lobbyist_client
- 2026-05-18 · lobbied by Corey Malmgren · lda_lobbyist_client
- 2026-01-01 · lobbied for by TIBER CREEK GROUP $80,000 · lda_filing
- 2026-01-01 · lobbied on Affordable Prescriptions for Patients Act (s. 1041) · lobbying_bill_mention
- 2026-01-01 · lobbied on Preserve Access to Affordable Generics and Biosimilars Act (s. 1096) · lobbying_bill_mention
- 2026-01-01 · lobbied on SAFE Drugs Act of 2025 (h.r. 6509) · lobbying_bill_mention
- 2026-01-01 · lobbied for by B HALL STRATEGIES, LLC $30,000 · lda_filing
Lobbying disclosures — as CLIENT (2)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-18 | 1st Quarter - Report | 2026 | first_quarter | 20744 | $80,000 | — |
| 2026-04-09 | 1st Quarter - Report | 2026 | first_quarter | 401109669 | $30,000 | — |
Aliases (2)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 67767 | TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | US | gold | backfill_0029 | |
| lda_client | 127294 | TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) | US | gold | backfill_0029 |
Outbound edges (3)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 6509 — SAFE Drugs Act of 2025 | — | H.R. 6509 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1041 — Affordable Prescriptions for Patients Act | — | S. 1041 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1096 — Preserve Access to Affordable Generics and Biosimilars Act | — | S. 1096 | lobbying_bill_mention |
Inbound edges (8)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Corey Malmgren | lobbied_for | — | lda_lobbyist_client |
| — | Timothy A Molino | lobbied_for | — | lda_lobbyist_client |
| — | Emily Kirlin | lobbied_for | — | lda_lobbyist_client |
| — | James Bryant Hall Ii | lobbied_for | — | lda_lobbyist_client |
| — | John Michael Gonzalez | lobbied_for | — | lda_lobbyist_client |
| — | Jonathon Jones | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | TIBER CREEK GROUP | lobbies_for | $80,000 | lda_filing |
| 2026-01-01 | B HALL STRATEGIES, LLC | lobbies_for | $30,000 | lda_filing |